NCT05761938View on ClinicalTrials.gov

A Study of Rituximab in Frontline Therapy for Glomerulonephritis

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

December 1, 2024

Study Completion Date

December 1, 2025

Conditions
Glomerulonephritis
Trial Locations (5)

Unknown

NOT_YET_RECRUITING

Changhai Hospital, Shanghai

NOT_YET_RECRUITING

Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

NOT_YET_RECRUITING

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

NOT_YET_RECRUITING

Shanghai 6th People's Hospital, Shanghai

RECRUITING

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

All Listed Sponsors
lead

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

OTHER